Key Laboratory of Pharmacology of Traditional Chinese Medical Formulae, Ministry of Education, Tianjin University of Traditional Chinese Medicine, Tianjin, China.
Tianjin State Key Laboratory of Modern Chinese Medicine, Tianjin University of Traditional Chinese Medicine, Tianjin, China.
Pharm Biol. 2023 Dec;61(1):391-403. doi: 10.1080/13880209.2023.2168019.
Fructus Ligustri Lucidi (FLL), a commonly used herb of traditional Chinese medicine (TCM), is the fruit of Ait. (Oleaceae). The ethanol extract of FLL is a potential candidate for preventing and treating postmenopausal osteoporosis (PMOP) by nourishing the liver and kidneys.
This study determines whether an ethanol extract of FLL has anti-osteoporotic effects in ovariectomized (OVX) mice and explores the underlying mechanism.
The OVX model of eight-week-old C57BL/6J female mice was taken, and ovariectomy was used as PMOP. Mice were divided into five groups: sham-operated group ( = 10), OVX group ( = 10), OVX + E group ( = 10; 0.039 mg/kg), OVX + FLL group ( = 10; 2 g/kg) and OVX + FLL group ( = 10; 4 g/kg). Mice were treated by gavage with FLL or CMCNa once daily for 8 weeks. We harvested uteri, femur, and tibias from mice; bone mineral density (BMD) and bone microstructure were obtained by X-ray absorptiometry and micro-CT. Furthermore, the effect of FLL on the balance of osteoblast and adipocyte differentiation was investigated using bone marrow mesenchymal stem cells (BMMSCs).
The results indicated that FLL did not affect OVX-induced estradiol reduction. Compared with OVX mice, FLL significantly increased BMD (63.54 vs. 61.96), Conn. D (86.46 vs. 57.00), and left tibial strength (13.91 vs. 11.27), decreased Tb. Sp (0.38 vs. 0.44) and body fat content (4.19% vs. 11.24%). FLL decreased osteoclast activity and enhanced RUNX2 expression; inhibited perilipin peroxisome proliferator-activated receptor gamma (PPARγ) expression and adipocyte differentiation from BMMSCs.
FLL prevented additional bone loss and improved bone microstructure in OVX mice by modulating bone and fat balance, suggesting that FLL might be a therapeutic agent for PMOP.
女贞子(FLL)是一种常用的中药(TCM)草药,是木樨科女贞属的果实。FLL 的乙醇提取物是预防和治疗绝经后骨质疏松症(PMOP)的潜在候选药物,具有滋补肝肾的功效。
本研究旨在探讨 FLL 乙醇提取物对去卵巢(OVX)小鼠的抗骨质疏松作用及其作用机制。
采用 8 周龄 C57BL/6J 雌性小鼠的 OVX 模型,采用卵巢切除术作为 PMOP。将小鼠分为 5 组:假手术组(n=10)、OVX 组(n=10)、OVX+E 组(n=10;0.039mg/kg)、OVX+FLL 组(n=10;2g/kg)和 OVX+FLL 组(n=10;4g/kg)。通过灌胃给予 FLL 或 CMCNa 每日一次,共 8 周。从小鼠中采集子宫、股骨和胫骨;通过 X 射线吸收法和微 CT 获得骨矿物质密度(BMD)和骨微观结构。此外,还通过骨髓间充质干细胞(BMMSCs)研究了 FLL 对成骨细胞和脂肪细胞分化平衡的影响。
结果表明,FLL 不影响 OVX 引起的雌二醇减少。与 OVX 小鼠相比,FLL 显著增加了 BMD(63.54 对 61.96)、Conn.D(86.46 对 57.00)和左胫骨强度(13.91 对 11.27),降低了 Tb.Sp(0.38 对 0.44)和体脂含量(4.19%对 11.24%)。FLL 降低了破骨细胞活性并增强了 RUNX2 的表达;抑制了 BMMSCs 中过氧化物酶体增殖物激活受体γ(PPARγ)表达和脂肪细胞分化。
FLL 通过调节骨与脂肪的平衡,防止 OVX 小鼠进一步骨丢失并改善骨微结构,提示 FLL 可能是治疗 PMOP 的药物。